UFH is a mixture of glycosaminoglycans of varying lengths (mean 15,000 daltons; range 3000-30,000 daltons). This heterogeneity results in variable anticoagulant activity and pharmacokinetics. In fact, ...

CHICAGO, IL — A small, single-center analysis suggests that it may be time to increase the recommended maximum, weight-based unfractionated-heparin bolus and infusion doses for patients with ACS so as ...

Unfractionated heparin is the standard anticoagulant used in interventional cardiology. Despite being used for the past 20 years in patients undergoing percutaneous coronary intervention (PCI), there ...

Therapeutic-dose heparin appears to benefit noncritically-ill COVID-19 patients, but it does not reduce deaths or other adverse endpoints compared with usual-care thromboprophylaxis if it’s initiated ...

Patients with high D-dimer levels who are hospitalized with COVID-19—but not those who require ICU-level care—stand to gain a reduction in major thromboembolism and death with therapeutic-dose low ...

Collaborative international clinical trials testing full dose anticoagulation with heparin (a blood thinner) in both moderately ill and critically ill patients has found the treatment improves ...

Survival at 28 Days among Patients with Sepsis Who Received Low-Dose (or Low-Molecular-Weight) Heparin as Compared with Those Who Did Not. Our findings are hypothesis-generating only, and caution is ...

The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according ...

Heparin entered clinical testing in the 1930s and, in combination with a vitamin K antagonist, was shown in the 1950s to be effective in the treatment of acute pulmonary embolism (MILESTONE 3).

CHICAGO (Reuters) - Baxter International Inc on Monday said it has temporarily stopped making the blood-thinner heparin in multi-dose vials after four patients who took the drug died and hundreds of ...

We read with concern the analysis by Davidson et al. (Sept. 26 issue). 1 They use the pooled placebo groups from two sepsis trials, divided into two groups — patients who either were receiving heparin ...

Baxter Healthcare has temporarily stopped manufacturing multi-dose vials of heparin sodium for injection due to reports of serious allergic reactions and hypotension in patients who receive high bolus ...